UPM Raflatac expands offering for medical device and healthcare labeling
UPM Raflatac has introduced RPMD (Raflatac permanent medical device) adhesives to further expanded its range of guaranteed, globally available and compliant pharmaceutical and healthcare label materials for the medical device and healthcare industries.
UPM Raflatac said that, today, there are over 500,000 types of medical and in vitro diagnostic medical devices available in the EU, with a medical device meaning anything from a contact lens or sticking plaster, to an X-ray machine or hip replacement component. In vitro diagnostic medical devices include things like HIV blood tests, pregnancy tests, and blood sugar monitoring systems for diabetics.
The RPMD adhesive range includes options for drug/device combination products, such as insulin pens, auto-injectors and inhalers, as well as blood donation labeling, sterilization pouches for medical devices, and infusion bags and bottles.
UPM Raflatac said combining selected paper and film face materials with an RPMD adhesive ensures adhesion with a tight mandrel hold on glass and plastic, as well as sterilization resistance and migration safety.
These materials are also compliant with the EU medical device regulations and in vitro diagnostics regulations, published in May 2017. The medical device directive includes the adoption of a unique device identification (UDI) system to mark and identify medical devices in the healthcare supply chain, with a 2020 implementation deadline. A UDI is a code printed on a label affixed to a device or its packaging, or even directly on the device itself, in both plain text and machine-readable format. A UDI consists of a device identifier and product identifier, with the latter’s data varying according to the type of device and the manufacturer's current practice.
Markku Pietarinen, manager, business segments and pharma, specials EMEIA at UPM Raflatac, said: ‘With our expanded offering for medical device and healthcare applications, including the RPMD adhesive and a selection of FSC and PEFC certified paper faces for pharmaceutical use, we can continue to address the needs of all our customers.
‘These innovative solutions are ideal for the combination product market, which is growing quickly as treatment continues to move away from the hospital and out into the field and the home.’
Stay up to date
Subscribe to the free Label News newsletter and receive the latest content every week. We'll never share your email address.